The Oncology Companion Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Oncology Companion Diagnostics Market?
The market size for oncology companion diagnostics has been expanding swiftly in the last few years. Its value was noted at $3.35 billion in 2024 and it is projected to increase to $3.8 billion in 2025, with a compound annual growth rate (CAGR) of 13.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oncology Companion Diagnostics Industry?
The Oncology Companion Diagnostics market is projected to reach $6.21 billion in terms of market size by 2029, with a compound annual growth rate (CAGR) of 13.0%.
Download Your Free Sample of the 2025 Oncology Companion Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Oncology Companion Diagnostics Market?
The drivers in the oncology companion diagnostics market are:
• Increasing cases of adverse drug reactions
• Rising demand for comprehensive genomic testing
• Growing global incidence of cancer
• Need for targeted therapy and rising number of clinical trials.
Global Market Segmentation: Identifying Major Oncology Companion Diagnostics Industry Segments
The oncology companion diagnostics market covered in this report is segmented –
1) By Product: Instrument, Consumables, Software
2) By Disease Type: Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types
3) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH) Or Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
4) By End User: Hospital, Pathology Or Diagnostic Laboratory, Academic Medical Center, Other End-Users
Pre-order the 2025 Oncology Companion Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Oncology Companion Diagnostics Market?
The trends in the oncology companion diagnostics market are:
• Advancements in diagnostic technologies are becoming a significant trend.
• The utilization of next-generation sequencing (NGS) is shaping the market.
• The integration of artificial intelligence (AI) is an emerging trend in oncology companion diagnostics.
• The development of point-of-care companion diagnostic devices and innovative testing technologies are key trends.
Who Are the Top Competitors & Leading Players in the Oncology Companion Diagnostics Market?
The major players in the oncology companion diagnostics market are:
• F. Hoffmann-La Roche Ltd
Regional Dominance: Which Area Leads the Global Oncology Companion Diagnostics Market 2025: In-Depth Analysis of Size, Share & Forecast Market?
North America was the largest region in the oncology companion diagnostic market in 2024
